Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma.

MLA

Bishop, Michael R., et al. “Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma.” Blood, vol. 116, no. 21, Nov. 2010, p. 3451. EBSCOhost, https://doi.org/10.1182/blood.V116.21.3451.3451.

APA

Bishop, M. R., Steinberg, S., Hardy, N. M., Pavletic, S. Z., Gress, R. E., Salit, R. B., Layton, P., & Fowler, D. H. (2010). Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma. Blood, 116(21), 3451. https://doi.org/10.1182/blood.V116.21.3451.3451

Chicago

Bishop, Michael R., Seth Steinberg, Nancy M. Hardy, Steven Z. Pavletic, Ronald E. Gress, Rachel B. Salit, Paula Layton, and Daniel H. Fowler. 2010. “Incidence, Risks, and Outcomes of Relapse Following Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma.” Blood 116 (21): 3451. doi:10.1182/blood.V116.21.3451.3451.